439 related articles for article (PubMed ID: 30672136)
1. Efficacy of systemic sirolimus in the treatment of generalized lymphatic anomaly and Gorham-Stout disease.
Ricci KW; Hammill AM; Mobberley-Schuman P; Nelson SC; Blatt J; Bender JLG; McCuaig CC; Synakiewicz A; Frieden IJ; Adams DM
Pediatr Blood Cancer; 2019 May; 66(5):e27614. PubMed ID: 30672136
[TBL] [Abstract][Full Text] [Related]
2. The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies.
Ozeki M; Nozawa A; Yasue S; Endo S; Asada R; Hashimoto H; Fukao T
Orphanet J Rare Dis; 2019 Jun; 14(1):141. PubMed ID: 31196128
[TBL] [Abstract][Full Text] [Related]
3. Clinical Features and Prognosis of Generalized Lymphatic Anomaly, Kaposiform Lymphangiomatosis, and Gorham-Stout Disease.
Ozeki M; Fujino A; Matsuoka K; Nosaka S; Kuroda T; Fukao T
Pediatr Blood Cancer; 2016 May; 63(5):832-8. PubMed ID: 26806875
[TBL] [Abstract][Full Text] [Related]
4. Sirolimus in the Treatment of Vascular Anomalies.
Triana P; Dore M; Cerezo VN; Cervantes M; Sánchez AV; Ferrero MM; González MD; Lopez-Gutierrez JC
Eur J Pediatr Surg; 2017 Feb; 27(1):86-90. PubMed ID: 27723921
[No Abstract] [Full Text] [Related]
5. Clinical and radiological improvement in Gorham-Stout disease after sirolimus treatment.
Barnes-Saldaña F; Venegas-Andrade A; Colin-Martínez Ó; Lizardo-Rodríguez A; García-Romero MT; Durán-McKinster C
Bol Med Hosp Infant Mex; 2023; 80(3):217-221. PubMed ID: 37467447
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of sirolimus treatment for intractable lymphatic anomalies: A study protocol for an open-label, single-arm, multicenter, prospective study (SILA).
Ozeki M; Asada R; Saito AM; Hashimoto H; Fujimura T; Kuroda T; Ueno S; Watanabe S; Nosaka S; Miyasaka M; Umezawa A; Matsuoka K; Maekawa T; Yamada Y; Fujino A; Hirakawa S; Furukawa T; Tajiri T; Kinoshita Y; Souzaki R; Fukao T
Regen Ther; 2019 Jun; 10():84-91. PubMed ID: 30705924
[TBL] [Abstract][Full Text] [Related]
7. Craniofacial CT findings of Gorham-Stout disease and generalized lymphatic anomaly.
Kato H; Ozeki M; Fukao T; Matsuo M
Neuroradiology; 2016 Aug; 58(8):801-6. PubMed ID: 27126342
[TBL] [Abstract][Full Text] [Related]
8. Gorham-Stout disease successfully treated with sirolimus (rapamycin): a case report and review of the literature.
Liang Y; Tian R; Wang J; Shan Y; Gao H; Xie C; Li J; Xu M; Gu S
BMC Musculoskelet Disord; 2020 Aug; 21(1):577. PubMed ID: 32843029
[TBL] [Abstract][Full Text] [Related]
9. Gorham-Stout disease and generalized lymphatic anomaly--clinical, radiologic, and histologic differentiation.
Lala S; Mulliken JB; Alomari AI; Fishman SJ; Kozakewich HP; Chaudry G
Skeletal Radiol; 2013 Jul; 42(7):917-24. PubMed ID: 23371338
[TBL] [Abstract][Full Text] [Related]
10. Complex Lymphatic Anomalies: Report on a Patient Registry Using the Latest Diagnostic Guidelines.
Andreoti TA; Berg S; Holm A; Angerer M; Oberlin M; Foeldi E; Baumgartner I; Niemeyer CM; Rössler J; Kapp FG
Lymphat Res Biol; 2023 Jun; 21(3):230-243. PubMed ID: 36706428
[No Abstract] [Full Text] [Related]
11. MR imaging findings of vertebral involvement in Gorham-Stout disease, generalized lymphatic anomaly, and kaposiform lymphangiomatosis.
Kato H; Ozeki M; Fukao T; Matsuo M
Jpn J Radiol; 2017 Oct; 35(10):606-612. PubMed ID: 28795277
[TBL] [Abstract][Full Text] [Related]
12. How we approach the diagnosis and management of complex lymphatic anomalies.
Ricci KW; Iacobas I
Pediatr Blood Cancer; 2022 Aug; 69 Suppl 3():e28985. PubMed ID: 33844431
[TBL] [Abstract][Full Text] [Related]
13. Complex lymphatic anomalies.
Trenor CC; Chaudry G
Semin Pediatr Surg; 2014 Aug; 23(4):186-90. PubMed ID: 25241096
[TBL] [Abstract][Full Text] [Related]
14. Personalized Therapy for Generalized Lymphatic Anomaly/Gorham-Stout Disease With a Combination of Sunitinib and Taxol.
Rössler J; Saueressig U; Kayser G; von Winterfeld M; Klement GL
J Pediatr Hematol Oncol; 2015 Nov; 37(8):e481-5. PubMed ID: 26458155
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of kaposiform lymphangiomatosis with sirolimus.
Wang Z; Li K; Yao W; Dong K; Xiao X; Zheng S
Pediatr Blood Cancer; 2015 Jul; 62(7):1291-3. PubMed ID: 25598153
[TBL] [Abstract][Full Text] [Related]
16. Gorham-Stout Disease Successfully Treated With Sirolimus and Zoledronic Acid Therapy.
Cramer SL; Wei S; Merrow AC; Pressey JG
J Pediatr Hematol Oncol; 2016 Apr; 38(3):e129-32. PubMed ID: 26886375
[TBL] [Abstract][Full Text] [Related]
17. Sirolimus on Gorham-Stout disease. Case report.
García V; Alonso-Claudio G; Gómez-Hernández MT; Chamorro AJ
Colomb Med (Cali); 2016 Dec; 47(4):213-216. PubMed ID: 28348444
[TBL] [Abstract][Full Text] [Related]
18. A New Case and Review of Chylothorax in Generalized Lymphatic Anomaly and Gorham-Stout Disease.
Ludwig KF; Slone T; Cederberg KB; Silva AT; Dellinger M
Lymphology; 2016 Jun; 49(2):73-84. PubMed ID: 29906363
[TBL] [Abstract][Full Text] [Related]
19. Generalized lymphatic anomaly successfully treated with long-term, low-dose sirolimus.
Dvorakova V; Rea D; O'Regan GM; Irvine AD
Pediatr Dermatol; 2018 Jul; 35(4):533-534. PubMed ID: 29582448
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary and pleural lymphatic endothelial cells from pediatric, but not adult, patients with Gorham-Stout disease and generalized lymphatic anomaly, show a high proliferation rate.
Mori M; Dictor M; Brodszki N; López-Gutiérrez JC; Beato M; Erjefält JS; Eklund EA
Orphanet J Rare Dis; 2016 May; 11(1):67. PubMed ID: 27194137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
